Zacks: Brokerages Anticipate The Ensign Group, Inc. (ENSG) Will Post Quarterly Sales of $504.30 Million

Share on StockTwits

Wall Street analysts expect that The Ensign Group, Inc. (NASDAQ:ENSG) will announce sales of $504.30 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for The Ensign Group’s earnings. The lowest sales estimate is $502.90 million and the highest is $505.70 million. The Ensign Group reported sales of $448.28 million during the same quarter last year, which indicates a positive year over year growth rate of 12.5%. The company is expected to announce its next earnings report on Thursday, August 2nd.

According to Zacks, analysts expect that The Ensign Group will report full year sales of $2.04 billion for the current financial year, with estimates ranging from $2.03 billion to $2.04 billion. For the next financial year, analysts expect that the business will post sales of $2.21 billion per share, with estimates ranging from $2.19 billion to $2.23 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that that provide coverage for The Ensign Group.

The Ensign Group (NASDAQ:ENSG) last posted its earnings results on Wednesday, May 2nd. The company reported $0.45 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.45. The Ensign Group had a return on equity of 14.77% and a net margin of 3.20%. The firm had revenue of $492.13 million for the quarter, compared to analyst estimates of $485.20 million. During the same quarter in the prior year, the company earned $0.34 EPS. The Ensign Group’s revenue was up 11.4% on a year-over-year basis.

ENSG has been the topic of several research reports. BidaskClub lowered The Ensign Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Zacks Investment Research lowered The Ensign Group from a “buy” rating to a “hold” rating in a research note on Wednesday, April 11th. Stifel Nicolaus increased their target price on The Ensign Group from $22.00 to $26.00 and gave the stock a “hold” rating in a research note on Thursday, May 3rd. Oppenheimer increased their price target on The Ensign Group from $31.00 to $39.00 and gave the company an “outperform” rating in a research report on Tuesday, May 22nd. Finally, Citigroup increased their price target on The Ensign Group from $31.00 to $39.00 and gave the company an “outperform” rating in a research report on Tuesday, May 22nd. Two analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $32.00.

In other The Ensign Group news, Director John G. Nackel sold 8,000 shares of the stock in a transaction dated Thursday, May 3rd. The stock was sold at an average price of $30.90, for a total value of $247,200.00. Following the sale, the director now owns 77,732 shares of the company’s stock, valued at approximately $2,401,918.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Suzanne D. Snapper sold 3,273 shares of the stock in a transaction dated Wednesday, May 23rd. The shares were sold at an average price of $35.00, for a total value of $114,555.00. Following the completion of the sale, the chief financial officer now directly owns 124,263 shares in the company, valued at approximately $4,349,205. The disclosure for this sale can be found here. Insiders sold a total of 12,096 shares of company stock worth $391,604 in the last ninety days. 6.00% of the stock is owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of the business. Advisor Group Inc. increased its holdings in shares of The Ensign Group by 104.4% in the 4th quarter. Advisor Group Inc. now owns 4,543 shares of the company’s stock valued at $101,000 after acquiring an additional 2,320 shares during the last quarter. Quantbot Technologies LP purchased a new position in shares of The Ensign Group in the 1st quarter valued at about $105,000. Mount Yale Investment Advisors LLC purchased a new position in shares of The Ensign Group in the 1st quarter valued at about $127,000. SG Americas Securities LLC purchased a new position in shares of The Ensign Group in the 1st quarter valued at about $138,000. Finally, Millennium Management LLC purchased a new position in shares of The Ensign Group in the 4th quarter valued at about $227,000. 85.53% of the stock is currently owned by institutional investors.

The Ensign Group traded down $0.47, hitting $35.82, during mid-day trading on Tuesday, according to MarketBeat.com. 292,904 shares of the stock were exchanged, compared to its average volume of 352,498. The Ensign Group has a 1-year low of $18.75 and a 1-year high of $40.09. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.53. The firm has a market cap of $1.86 billion, a price-to-earnings ratio of 25.96, a PEG ratio of 1.39 and a beta of 0.68.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 31st. Shareholders of record on Saturday, June 30th will be given a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a yield of 0.50%. The ex-dividend date of this dividend is Thursday, June 28th. The Ensign Group’s dividend payout ratio is currently 15.00%.

The Ensign Group Company Profile

The Ensign Group, Inc provides health care services in the post-acute care continuum and other ancillary businesses in the United States. It operates through three segments: Transitional and Skilled Services; Assisted and Independent Living Services; and Home Health and Hospice Services. The Transitional and Skilled Services segment offers a range of medical, nursing, rehabilitative, and pharmacy services, as well as routine services, including daily dietary, social, and recreational services to Medicaid, private pay, managed care, and Medicare payors.

Get a free copy of the Zacks research report on The Ensign Group (ENSG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.